Value8 N.V (VALUE) Fair Value & Analysis
Financial Services · NL · Market cap €65.3M
Fair value as of: Jun 26, 2026
From 16 valuation models · updated 18 days ago
Share price −0.7% over the past month.
Price vs Fair Value (12 months)
12‑month range €5.91 – €6.85 · fair‑value band €10.13 – €16.87 · the €6.75 price screens below the €13.50 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Value8 N.V (VALUE) currently trades at €6.75, while our model-based Fair Value estimate is €13.50 — implying the stock looks roughly 100.0% undervalued today. We read business quality at 65/100 (solid quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Value8 N.V generated revenue of €20.3M at a net margin of 83.1%. Revenue declined 11.6% year over year. It earns a return on equity of 15.2%. Net debt stands at €17.5M. Fundamentals as of Jun 26, 2026
Our scenario range runs from €10.13 (bear case) to €16.87 (bull case); at €6.75, the current price sits below that range. The share trades about 6% below its 52-week high and 20% above its 52-week low, currently above its 200-day average. For context, the median of 10 Financial Services peers we cover trades at 53% fair-value upside — at 100%, VALUE screens cheaper than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Value8 N.V. is a private equity firm specializing in middle market, buyout, add-on and growth capital investments in small and medium-sized companies. The firm primarily invests in the food, healthcare, business and financial services, energy, safety and security, water and environment, leisure, luxury products and internet sectors. It typically invests in Western Europe, primarily in the Netherlands, Belgium and France. The firm considers investments in companies with an enterprise value between "10 million ($10.74 million) and "150 million ($208.87 million). The firm prefers to take a seat on the board of directors and seeks to exit the investment through a public listing. Value8 NV was founded in 2008 and is headquartered in Bussum, Netherlands.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Value8 N.V reported revenue of €2.9M in FY2025 versus €4.2M in FY2021, a compound −8.9%/yr. Reported net income was €16.9M in FY2025, compounding −2.2%/yr from FY2021.
Is VALUE fairly valued? → Check now
Similar stocks
10 more Asset Management stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Fondul Proprietatea SA FP | $4.20 | $6.41 | +53% |
| The Schiehallion Fund Limited MNTN | $2.27 | $4.54 | +100% |
| BlackRock, Inc BLK | $1,052 | $465.03 | -56% |
| BH Macro Limited BHMU | $4.42 | $8.84 | +100% |
| Blackstone Inc BX | $123.26 | $52.88 | -57% |
| Investor AB INVEB | kr 388.65 | kr 1,430 | +268% |
| BioPharma Credit PLC BPCR | $0.9600 | $1.47 | +53% |
| Brookfield Corporation BN | $43.94 | $9.95 | -77% |
| KKR & Co KKR | C$21.40 | C$5.61 | -74% |
| Brookfield Asset Management Ltd BAM | C$63.81 | C$41.56 | -35% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Value8 N.V (VALUE) undervalued?
What is the fair value of VALUE?
What is the quality score of VALUE?
What is the revenue of Value8 N.V (VALUE)?
What is the net profit margin of VALUE?
Does Value8 N.V pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Unlock the full Value8 N.V analysis — and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.